Pharma Industry News

STAT+: U.S. Supreme Court asks solicitor general for views on controversial Oklahoma law for regulating PBMs

Amid ongoing scrutiny of pharmacy benefit managers, the U.S. Supreme Court has asked the solicitor general to weigh in on an Oklahoma law that seeks to regulate the retail networks created by these controversial middlemen in the pharmaceutical supply chain.

The law, which was enacted in 2019, was designed to ensure that pharmacy benefit managers maintain access to a large number of pharmacies and do not steer patients to favored outlets, among other things. The move came amid increased concern that opaque business practices were raising prescription drug costs for consumers and health plans, often by squeezing independently owned pharmacies.

But the Pharmaceutical Care Management Association, a trade group for pharmacy benefit managers, sued to block the law and objected to Oklahoma’s attempt to “interfere” with efforts to administer health plans that promote “affordable choices” for patients. Specifically, the group argued the law was preempted under the Employee Retirement Income S..

Amid ongoing scrutiny of pharmacy benefit managers, the U.S. Supreme Court has asked the solicitor general to weigh in on an Oklahoma law that seeks to regulate the retail networks created by these controversial middlemen in the pharmaceutical supply chain.

The law, which was enacted in 2019, was designed to ensure that pharmacy benefit managers maintain access to a large number of pharmacies and do not steer patients to favored outlets, among other things. The move came amid increased concern that opaque business practices were raising prescription drug costs for consumers and health plans, often by squeezing independently owned pharmacies.

But the Pharmaceutical Care Management Association, a trade group for pharmacy benefit managers, sued to block the law and objected to Oklahoma’s attempt to “interfere” with efforts to administer health plans that promote “affordable choices” for patients. Specifically, the group argued the law was preempted under the Employee Retirement Income Security Act and the Medicare Part D program.

Continue to STAT+ to read the full story…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]